What is he best known for?
The fields of study he is best known for:
- Enzyme
- Gene
- Internal medicine
Vincenzo Di Marzo spends much of his time researching Endocannabinoid system, Cannabinoid receptor, Cannabinoid, Anandamide and Internal medicine.
His Endocannabinoid system study is related to the wider topic of Receptor.
His study focuses on the intersection of Cannabinoid receptor and fields such as Cancer research with connections in the field of Metastasis and Cancer cell.
His Cannabinoid research includes elements of AM404, TRPV1, Mechanism of action, Cannabinoid receptor type 2 and Stimulation.
His Anandamide research includes themes of Oleamide, Palmitoylethanolamide, Fatty acid amide hydrolase and Cell biology.
His work in Internal medicine covers topics such as Endocrinology which are related to areas like Trk receptor.
His most cited work include:
- Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide (1878 citations)
- The endogenous cannabinoid system controls extinction of aversive memories (1430 citations)
- Leptin-regulated endocannabinoids are involved in maintaining food intake (1378 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Endocannabinoid system, Cannabinoid receptor, Cannabinoid, Internal medicine and Anandamide.
His Endocannabinoid system research is multidisciplinary, incorporating elements of Palmitoylethanolamide, Neuroscience and Pharmacology.
Many of his studies on Cannabinoid receptor apply to Cell biology as well.
The Cannabinoid study combines topics in areas such as Cannabinoid Receptor Modulators, TRPV1, Cannabidiol, Inverse agonist and Stereochemistry.
Internal medicine is closely attributed to Endocrinology in his study.
His Anandamide course of study focuses on Fatty acid amide hydrolase and Monoacylglycerol lipase.
He most often published in these fields:
- Endocannabinoid system (56.57%)
- Cannabinoid receptor (43.58%)
- Cannabinoid (39.83%)
What were the highlights of his more recent work (between 2016-2021)?
- Endocannabinoid system (56.57%)
- Internal medicine (30.30%)
- Endocrinology (29.87%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Endocannabinoid system, Internal medicine, Endocrinology, Cannabinoid receptor and Pharmacology.
His Endocannabinoid system research also works with subjects such as
- Neuroscience which is related to area like Orexin,
- Anandamide together with Fatty acid amide hydrolase.
His study in Endocrinology is interdisciplinary in nature, drawing from both Prefrontal cortex, Phthalate and Gut–brain axis.
The concepts of his Cannabinoid receptor study are interwoven with issues in Inverse agonist, Cannabinoid and Cell biology.
He usually deals with Cannabinoid and limits it to topics linked to Cannabidiol and Epilepsy.
Vincenzo Di Marzo studied Pharmacology and Palmitoylethanolamide that intersect with Oleoylethanolamide.
Between 2016 and 2021, his most popular works were:
- Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 (155 citations)
- Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity (140 citations)
- New approaches and challenges to targeting the endocannabinoid system (136 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Gene
- Internal medicine
Vincenzo Di Marzo mainly investigates Endocannabinoid system, Endocrinology, Internal medicine, Pharmacology and Receptor.
His Endocannabinoid system study incorporates themes from Microbiome, Bioinformatics, Microglia, Cannabinoid receptor and Neuroscience.
Vincenzo Di Marzo has researched Cannabinoid receptor in several fields, including Haloperidol, Quantitative structure–activity relationship, Cannabinoid and Monoacylglycerol lipase.
Vincenzo Di Marzo interconnects Anandamide, Gut flora and Phthalate in the investigation of issues within Endocrinology.
His work carried out in the field of Pharmacology brings together such families of science as Inflammation, Nicotine withdrawal, Nicotine, Cannabinoid receptor type 2 and Palmitoylethanolamide.
His studies deal with areas such as In silico and Cell biology as well as Receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
